Nifty

:

22550.10

Sensex

:

74126.66

-98.10 (-0.43%)
-484.45 (-0.65%)

Login

Nifty
Sensex

:
:

22550.10
74126.66

-98.10 (-0.43%)
-484.45 (-0.65%)

Asarfi Hospital Ltd.

Hospital & Healthcare Services

Rating :

44/99

BSE: 543943 | NSE: Not Listed

Watchlist

NSE BSE

76.26

02-May-2024

Open
High
Low
Previous Close

76.25
78.00
76.00
74.60

Volume
Traded Value (lacs)
52 Week High
52 Week Low

12
11.56
145.75
55.50

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

150.06
18.72
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

158.74
N/A
2.18

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-
-

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
-

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-

P:E (Median)

8 Years
5 Years
3 Years

-

P:BV (Average)

8 Years
5 Years
3 Years

-

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-

Quarterly Results

N/A

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 23 Mar 22
Net Sales - 68.82 65.19 Net Sales Growth - 5.57% Cost Of Goods Sold - 20.02 25.67 Gross Profit - 48.80 39.53 GP Margin - 70.91% 60.64% Total Expenditure - 55.05 54.41 Power & Fuel Cost - 1.46 1.31 % Of Sales - 2.12% 2.01% Employee Cost - 10.80 8.10 % Of Sales - 15.69% 12.43% Manufacturing Exp. - 4.08 2.90 % Of Sales - 5.93% 4.45% General & Admin Exp. - 17.21 14.84 % Of Sales - 25.01% 22.76% Selling & Distn. Exp. - 0.00 0.00 % Of Sales - 0% 0% Miscellaneous Exp. - 1.48 1.59 % Of Sales - 2.15% 2.44% EBITDA - 13.77 10.78 EBITDA Margin - 20.01% 16.54% Other Income - 2.33 0.98 Interest - 1.34 0.70 Depreciation - 3.87 3.35 PBT - 10.89 7.72 Tax - 2.87 1.99 Tax Rate - 26.35% 25.78% PAT - 8.02 5.73 PAT before Minority Interest - 8.02 5.73 Minority Interest - 0.00 0.00 PAT Margin - 11.65% 8.79% PAT Growth - 39.97% EPS - 4.07 2.91

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22
Shareholder's Funds 41.84 22.63 Share Capital 14.50 1.25 Total Reserves 27.35 21.38 Non-Current Liabilities 31.99 25.31 Secured Loans 10.79 5.99 Unsecured Loans 0.00 0.00 Long Term Provisions 0.71 0.31 Current Liabilities 19.59 14.76 Trade Payables 4.99 2.40 Other Current Liabilities 3.93 4.32 Short Term Borrowings 6.41 5.65 Short Term Provisions 4.26 2.40 Total Liabilities 93.42 62.70 Net Block 38.57 30.87 Gross Block 59.44 47.87 Accumulated Depreciation 20.87 17.00 Non Current Assets 56.92 40.62 Capital Work in Progress 17.91 9.34 Non Current Investment 0.00 0.00 Long Term Loans & Adv. 0.44 0.41 Other Non Current Assets 0.00 0.00 Current Assets 36.51 22.08 Current Investments 0.00 0.00 Inventories 1.42 1.09 Sundry Debtors 16.93 5.33 Cash & Bank 8.52 13.72 Other Current Assets 9.64 0.00 Short Term Loans & Adv. 9.64 1.94 Net Current Assets 16.92 7.32 Total Assets 93.43 62.70

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22
Cash From Operating Activity -2.07 9.26 PBT 10.89 7.72 Adjustment 4.99 3.75 Changes in Working Capital -15.91 -0.26 Cash after chg. in Working capital -0.03 11.21 Interest Paid 0.00 0.00 Tax Paid -2.03 -1.95 Other Direct Exp. Paid 0.00 0.00 Extra & Other Items 0.00 0.00 Cash From Investing Activity -13.65 -23.16 Net Fixed Assets -20.14 Net Investments 0.00 Others 6.49 Cash from Financing Activity 16.82 13.77 Net Cash Inflow / Outflow 1.10 -0.13 Opening Cash & Equivalents 0.20 0.33 Closing Cash & Equivalent 1.30 0.20

Financial Ratios

Standalone

Right to Left

Description Mar 23 Mar 22
Book Value (Rs.) 28.86 30.18 ROA 10.27% 11.46% ROE 24.87% 28.99% ROCE 26.21% 28.88% Fixed Asset Turnover 1.28 1.55 Receivable days 59.02 20.79 Inventory Days 6.67 5.35 Payable days 67.33 27.09 Cash Conversion Cycle -1.63 -0.96 Total Debt/Equity 0.41 0.51 Interest Cover 9.13 11.99

Top Investors:

jitendra kumar jain

india-ahead venture fund

sukanti kumar das

ang corporate services private limited

Annual Reports:

News Update:

No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback